Home › Trial NCT01765556
A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
- Trial IDNCT01765556
- StatusWithdrawn
- PhasePhase 1
- Study typeInterventional
- SponsorHoffmann-La Roche
- Enrollment—
- Start date2013-10
- ConditionsMalignant Melanoma, Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.